Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil

Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/1478-7547-11-25
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

New England Journal of Medicine
Medicine
2000English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal
Medicine
2011English

Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Gastroenterology
HepatologyGastroenterology
2011English

Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response

PLoS ONE
Multidisciplinary
2014English

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study

Hepatology
MedicineHepatology
2018English

Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy

Acta Hepatologica Japonica
Hepatology
2012English

Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a

Virology Journal
VirologyInfectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy